the sun malaysia ipaper logo 150x150
Friday, July 3, 2026
28.6 C
Kuala Lumpur
the sun malaysia ipaper logo 150x150

Avoid consuming mussels, clams for time being – Aminuddin

SEREMBAN: People in the state are advised against consuming mussels, clams and other bivalves, especially from Port Dickson waters for the time being, said Menteri Besar Datuk Seri Aminuddin Harun.

He said that this was due to the state Department of Fisheries (DOF) still conducting observations and analyses of water and bivalves in the areas.

“We used to hear about food poisoning involving mussels and clams, but it has not occurred for a long time. However, it recently recurred in Port Dickson, the DOF has also informed the cause. We also know that there are several farmers involved in mussel farming in the area. We hope the public will avoid it until this issue is resolved.

“The state government will see what kind of action it will take, because we have not yet received a full report from the state DOF, including the number of farmers involved and so on,” he told reporters after attending the opening of a supermarket here today.

On April 4, the DOF deputy director-general (Management) Wan Aznan Abdullah reportedly said that the laboratory analysis of the Kuala Lumpur Fisheries Biosecurity Centre found that there was harmful algae, which caused the mussels in Port Dickson waters to be contaminated and unsafe to eat.

He said that water samples and mussels in the waters were contaminated with biotoxins, as well as harmful Prorocentrum, Alexandrium and Pseudonitzschia algae species.

STAY AHEAD OF THE CURVE

Join our community for instant updates and exclusive content.

Join Telegram Channel

Related


spot_img

Latest News

Bora Pharmaceuticals Completes Acquisition of MacroGenics’ Rockville Manufacturing Operations

TAIPEI, TAIWAN - Media OutReach Newswire - 2 July 2026 - Bora Pharmaceuticals Co., Ltd. ("Bora" or "Bora Group"; TWSE: 6472; OTCQX: BORAY) today announced the completion of its acquisition of the GMP manufacturing operations of MacroGenics, Inc. (NASDAQ: MGNX) including its biologics drug substance facility in Rockville, Maryland and an associated warehousing center in Frederick, Maryland, for total consideration of US $122.5 million through its wholly owned subsidiary Bora Biologics USA, LLC.. Upon closing, Bora signed a long-term CDMO Service Agreement with MacroGenics.

Most Viewed

spot_img
WC26

World Cup 2026

Updates, Fixtures, Results & Standings